Selective serotonin reuptake inhibitor discontinuation syndrome: Three cases presenting to a neurologic practice

Neurologist

Volumn 6, Issue 6, 2000, Pages 348-352

  Rivas Vazquez, R A ^a   Carrazana, E J ^a   Rey, G J ^a   Wheeler, S D ^a  

^a NONE   (United States)

Author keywords

Discontinuation syndrome; Downregulation; Selective serotonin reuptake inhibitor

Indexed keywords

PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; ARTICLE; CASE REPORT; DEPRESSION; DOSE CALCULATION; DOWN REGULATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABILITY; MALE; PATIENT EDUCATION; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SLEEP DISORDER; WITHDRAWAL SYNDROME;

EID: 0033653862     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-200006060-00005     Document Type: Article

References (25)

1. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition
2. The abrupt discontinuation of fluvoxamine in patients with panic disorder
3. Is there a serotonergic withdrawal syndrome?
4. Physician's knowledge of antidepressant withdrawal effects: A survey
5. Serotonin reuptake inhibitor withdrawal
6. Newer antidepressants and the discontinuation syndrome
7. Antidepressant discontinuation: A review of the literature
8. Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome
9. How do antidepressants affect serotonin receptor? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs
10. Withdrawal symptoms after discontinuation of selective serotonin reuptake inhibitors (SSRIs)
11. Pharmacokinetics of antidepressants: Why and how they are relevant to treatment
12. Discontinuation symptoms after treatment with serotonin reuptake inhibitor: A literature review
13. Adverse events after abrupt discontinuation of paroxetine
14. Potential withdrawal syndrome associated with SSRI discontinuation
15. Discontinuation symptoms and the SSRIs
16. Discontinuation of antidepressant therapy: Emerging complications and their relevance
17. The safety and tolerability of citalopram
18. Withdrawal syndrome after discontinuation of venlafaxine
19. Possible venlafaxine withdrawal syndrome
20. Nefazodone withdrawal symptoms
21. Withdrawal reactions associated with venlafaxine
22. Clinical management of antidepressant discontinuation
23. More cases of paroxetine withdrawal syndrome
24. Antidepressant noncompliance as a factor in the discontinuation syndrome